FDA Opioid Progression: KemPharm's Combo To Get Cmte. Vote After Policy Review
This article was originally published in The Pink Sheet Daily
Relevance of nasal abuse will be factor for benzhydrocodone/acetaminophen product that is designed to be crush resistant.
Register for our free email digests: